F.D.A. Panel Urges Denial of Diet Drug
Thursday, September 16, 2010 - 23:56
in Health & Medicine
By a 9-to-5 vote, the advisers decided that the potential benefits of the drug lorcaserin, from Arena Pharmaceuticals, did not outweigh risks.